Jutta Deckert
13Patents
5h-index
17Co-inventors
59Inventor score
Filing activity: Oct 16, 2007 → Jul 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8153765B2 | Anti-CD38 antibodies for the treatment of cancer | Physics | 60 | Active |
| US8765917B2 | CD37-binding molecules and immunoconjugates thereof | Physics | 14 | Active |
| US9346887B2 | CD37-binding molecules and immunoconjugates thereof | Physics | 9 | Active |
| US9447189B2 | CD37-binding molecules and immunoconjugates thereof | Chemistry; Metallurgy | 7 | Active |
| US9173961B2 | CD20 antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US10556958B2 | CD37-binding molecules and immunoconjugates thereof | Chemistry; Metallurgy | 5 | Active |
| US10202460B2 | CD37-binding molecules and immunoconjugates thereof | Physics | 5 | Active |
| US11395796B2 | Anti-CD37 immunoconjugate and anti-CD20 antibody combinations | Chemistry; Metallurgy | 3 | Active |
| US11104740B2 | Antibodies and assays for detection of CD37 | Physics | 1 | Active |
| US11466095B2 | CD37-binding molecules and immunoconjugates thereof | Physics | 1 | Active |
| US9314522B2 | Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib | Chemistry; Metallurgy | 0 | Active |
| US9175086B2 | CD20 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12239732B2 | Anti-CD37 immunoconjugate and anti-CD20 antibody combinations | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.